Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
pmid27998201-compound-12 cathepsin b NA Preclinical target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
Pain[MeSHID:D010146]
Malignant Bone Neoplasm[MeSHID:D001859]
NA patented unknown
pmid27998201-compound-12 cathepsin f NA Patented-recorded target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
Pain[MeSHID:D010146]
Malignant Bone Neoplasm[MeSHID:D001859]
NA patented unknown
pmid27998201-compound-12 cathepsin k NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
Pain[MeSHID:D010146]
Malignant Bone Neoplasm[MeSHID:D001859]
NA patented unknown
pmid27998201-compound-12 cathepsin l NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
Pain[MeSHID:D010146]
Malignant Bone Neoplasm[MeSHID:D001859]
NA patented unknown
pmid27998201-compound-12 cathepsin s NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
Pain[MeSHID:D010146]
Malignant Bone Neoplasm[MeSHID:D001859]
NA patented unknown
pmid27998201-compound-12 cathepsin v NA Patented-recorded target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
Pain[MeSHID:D010146]
Malignant Bone Neoplasm[MeSHID:D001859]
NA patented unknown
click here to return to the previous page